Premium Information is available for this item - Upgrade for $1 a day

6505-00-063-5638

Usp Riboflavin Tablets

6505000635638 000635638 1645 7815

6505-00-063-5638 RIBOFLAVIN TABLETS,USP 6505000635638 000635638

Managed by United States
NSN Created on 1 Jan 1961
Data Last Changed
November 2023
NATO Update Count
8
NATO Data Quality
6505-00-063-5638 RIBOFLAVIN TABLETS,USP 6505000635638 000635638 1/1
NSN 6505-00-063-5638 (Generic Image) 1/1

6505-00-063-5638 Stock and Availability Marketplace 6505-00-063-5638

Need Help?
Request a Quotation from participating marketplace vendors
eBay Updated Every Day
6505-00-063-5638 RQST NE eBay
eBay Updated Every Day
6505-00-063-5638 RQST eBay
Amazon Updated Every Day
6505-00-063-5638 RQST NE Amazon

6505-00-063-5638 Related Documents Related Documents 6505-00-063-5638 5+ Documents (More...)

-00-139-5000 Usp Riboflavin Tablets 6505001395000 210-1721 6505-99-210-1719 6505-15-055-0424 6505-00-063-5638
067-7170 Usp Riboflavin Tablets 6505000677170,1709 210-1721 6505-99-210-1719 6505-15-055-0424 6505-00-063-5638
055-0424 Riboflavin Tablets 6505150550424 150550424 210-1721 6505-99-210-1719 6505-15-055-0424 6505-00-063-5638
Riboflavin Tablets 6505001395000 857-5928 6505-99-210-1721 6505-99-210-1719 6505-15-055-0424 6505-00-063-5638
Riboflavin Tablets 6505000677170,1709 857-5928 6505-99-210-1721 6505-99-210-1719 6505-15-055-0424 6505-00-063-5638
Tablets 6505150550424 150550424 857-5928 6505-99-210-1721 6505-99-210-1719 6505-15-055-0424 6505-00-063-5638
6505000677170,1709 067-7170 6505-21-857-5928 6505-99-210-1721 6505-99-210-1719 6505-15-055-0424 6505-00-063-5638
6505-00-139-5000 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-063-5638 Usp Riboflavin Tablets
6505000635638,1645 067-7170 6505-21-857-5928 6505-99-210-1721 6505-99-210-1719 6505-15-055-0424 6505-00-063-5638
-0424 Related to 6505-00-139-5000 6505-00-067-7170 6505-21-857-5928 6505-99-210-1721 6505/us 6505-00-063-5638
Riboflavin Tablets 6505000677170,1709 067-7170 6505-21-857-5928 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-063-5638
857-5928 6505-00-067-7170 6505-21-857-5928 6505-99-210-1721 6505-99-210-1719 6505-15-055-0424 6505-00-063-5638
6505-99-210-1721 6505-99-210-1719 6505-15-055-0424 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-063-5638
Usp Riboflavin Tablets 6505000635638,1645 Related to 6505-00-063-5638 6505-00-067-7170 6505-21-
055-0424 6505-00-067-7170 6505-21-857-5928 6505-99-210-1721 6505-99-210-1719 6505-15-055-0424 6505-00-063-5638

6505-00-063-5638 Demil Restrictions 6505-00-063-5638

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: P | PMIC: U | EDC: | ADPEC:

6505-00-063-5638 is a Usp Riboflavin Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.

6505-00-063-5638 End Users End Users 6505-00-063-5638

NASA (G57V)
Effective Date:
1 Apr 1991

6505-00-063-5638 Manufacturers Approved Sources 6505-00-063-5638

6505-00-063-5638 Technical Data Datasheet 6505-00-063-5638

Characteristic
Specifications
Active Medicament Medicinal Strength [AKJA]
5.000 Milligrams Riboflavin Active Ingredient
Administration [CSGS]
Oral
Primary Container Type [CQCT]
Bottle
Primary Container Content Quantity [CRLK]
500.000 Tablets

6505-00-063-5638 Related Items NATO Stock Numbers Related to 6505-00-063-5638

6505-00-063-5638 Freight Data Freight Information 6505-00-063-5638

6505-00-063-5638 has freight characteristics.. 6505-00-063-5638 has a variance between NMFC and UFC when transported by rail and the description should be consulted.